Trial Profile

Research for immunotherapy of glioblastoma with autologous heat shock protein gp96

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs HSP Gp96 vaccine Cure and Sure Biotech (Primary)
Indications Glioblastoma
Focus Adverse reactions; Therapeutic Use
Sponsors Cure&Sure Biotech

Most Recent Events

10 Dec 2015 Planned End Date changed from 1 Jun 2017 to 1 Jan 2018 as reported by ClinicalTrials.gov.
10 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
13 Jul 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com